Pay in 4 interest-free payments of $7.31 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Bimagrumab is a human monoclonal antibody drug, whose mechanism of action stimulates the growth of skeletal muscle by blocking the activin type II receptor (ActRII)
PubMed Marso, S.P., Bain, S.C., Consoli, A., Eliaschewitz, F.G., Jdar, E., Leiter, L.A., et al
Front Cell Infect Microbiol 11:625913 Cho SS, Lee JH, Kim KM, Park EY, Ku SK, Cho IJ, Ki SH (2021) REDD1 attenuates hepatic stellate cell activation and liver fibrosis via inhibiting of TGF-/Smad signaling pathway
15ml (1/2oz) Citations: 0
Since then, several human GLP-1 RAs, such as liraglutide, dulaglutide, semaglutide, and tirzepatide, have been developed, offering enhanced pharmacokinetic properties for more convenient administration [1]
US$ 23.32
US$ 22.68
US$ 26.43
US$ 25.01
